AUS
NZ
UK
CA
USA
IND
Healthcare
Why S&P 500 Index Healthcare Stocks Driving Medical Devices?
May 28, 2026 10:15 PM PDT| By Anmol KhazanchiHealthcare Stocks including Intuitive Surgical, Stryker, and Boston Scientific operate across robotic surgery, orthopaedics, and cardiovascular devices amid evolving healthcare technology demand.
Three Pharma Giants Driving the Obesity Drug Boom
May 28, 2026 03:38 PM PDT| By Anmol KhazanchiObesity and metabolic drugs have reshaped pharma. Three US-listed names span the leaders and challengers in a market with vast potential and intensifying competition.
Bruker Shares Surge Following Strong (NASDAQ:BRKR) And Analyst Revisions
May 28, 2026 01:30 PM PDT| By Anmol KhazanchiBruker shares moved sharply higher after stronger earnings, upbeat analyst sentiment, and growing attention toward scientific research and laboratory technology demand.
Why Eli Lilly’s Latest Healthcare Move Is Drawing Attention?
May 28, 2026 01:16 PM PDT| By Anmol KhazanchiEli Lilly remains in focus as obesity drug access, oral treatment progress, clinical updates, and manufacturing expansion strengthen its long-term pharmaceutical growth narrative.
Agilent Technologies Momentum Lifts Market Confidence
May 28, 2026 12:59 PM PDT| By Anmol KhazanchiAgilent Technologies remains in focus as stronger analytical instrument demand, operational execution, and expanding scientific technology adoption continue shaping broader market sentiment.
Medical Device Giants Compounding Through Innovation
May 27, 2026 03:25 PM PDT| By Anmol KhazanchiMedical device businesses with established franchises continue to compound through innovation cycles. Three US-listed names span diversified medical technologies with consistent dividend records.
Big Pharma Names Driving Healthcare Sector Returns
May 27, 2026 03:18 PM PDT| By Anmol KhazanchiBig Pharma businesses with strong drug pipelines have driven healthcare sector returns. Three US-listed names anchor the conversation across multiple therapeutic categories.
Eli Lilly Vaccine Push Fuels NYSE Composite Focus
May 27, 2026 08:26 AM PDT| By Anmol KhazanchiLilly’s vaccine expansion broadens its healthcare pipeline beyond obesity and diabetes, adding infectious disease prevention while increasing attention on capital allocation, integration progress, and long-term diversification.
Why Haemonetics NYSE Composite Earnings Sparked Attention?
May 27, 2026 07:51 AM PDT| By Anmol KhazanchiHighlights,Unusual expenses affected earnings performance.,Healthcare technology demand remained stable.,Market focus shifted toward long-term profitability.,Haemonetics drew market attention after unusual accounting expenses weighed on earnings resu...
U.S. Healthcare Risks Reshaping S&P 500 Exposure
May 26, 2026 05:05 PM PDT| By Anmol KhazanchiU.S. healthcare companies continue navigating patent exposure, pricing pressure, regulatory oversight, and clinical trial uncertainty as evolving healthcare trends reshape industry dynamics across pharmaceuticals, biotechnology, insurance.
Healthcare Giants in the S&P 500: A Smarter Way to Evaluate Sector Leaders
May 26, 2026 05:01 PM PDT| By Anmol KhazanchiHealthcare companies are evaluated through pipeline strength, patent durability, regulatory expertise, and competitive positioning, helping market participants better understand long-term sector dynamics across pharmaceuticals, managed care.
Top Healthcare Stocks To Watch In U.S. Markets
May 26, 2026 04:50 PM PDT| By Anmol KhazanchiU.S. healthcare stocks across the S&P 500 include pharma leaders Eli Lilly, Pfizer, insurer UnitedHealth Group, medical device makers, and biotech innovators across NYSE and NASDAQ markets.
Doximity AI Push Reshapes Healthcare Tech On Russell 1000
May 25, 2026 02:48 PM PDT| By Anmol KhazanchiHighlights,Doximity expands AI healthcare workflow integration.,Leadership transition signals a new operational phase.,AI infrastructure costs remain a major focus.,Healthcare technology platforms are accelerating AI integration into physician workfl...
Hinge Health Growth Story Gains Momentum In Digital Care Space
May 25, 2026 02:41 PM PDT| By Anmol KhazanchiDigital healthcare company Hinge Health continues attracting attention as AI-driven care delivery, virtual rehabilitation services, and expanding enterprise healthcare adoption reshape market discussions around healthcare technology growth.
PACS Group Growth Story Gains Attention Amid Healthcare Expansion
May 25, 2026 02:35 PM PDT| By Anmol KhazanchiHealthcare operator PACS Group strengthened market attention after reaffirming its outlook, advancing operational momentum, and emphasizing expansion discussions alongside fresh capital allocation initiatives within the evolving post-acute care secto...
Dentsply Sirona Shares In Focus As Nasdaq Futures Climb Higher
May 25, 2026 02:09 PM PDT| By Anmol KhazanchiDENTSPLY SIRONA remains in focus as revenue stability, insider activity, and digital dentistry expansion strengthen attention around the healthcare technology company’s evolving market position.
GE HealthCare Faces Fresh Market Pressure Amid Healthcare Sector Volatility
May 25, 2026 01:54 PM PDT| By Anmol KhazanchiHealthcare technology markets remain active as GE HealthCare navigates operational challenges, imaging innovation trends, and evolving healthcare demand while maintaining focus on AI-driven diagnostic solutions.
Fortrea Gains Attention As Drug Development Services Sector Evolves
May 25, 2026 01:32 PM PDT| By Anmol KhazanchiThe healthcare research services sector continues evolving as biotechnology innovation, clinical outsourcing, and digital transformation reshape pharmaceutical development across global markets.
CVS Health Valuation Puts S&P 500 Index In Focus
May 25, 2026 07:56 AM PDT| By Anmol KhazanchiCVS Health remains in focus as valuation debate, medical cost pressure, restructuring execution, and healthcare strategy shape the company’s broader market narrative.
Why Is Teva Facing NYSE Pressure Amid EU Drug Filing Buzz?
May 24, 2026 11:04 PM PDT| By Anmol KhazanchiTeva Pharmaceutical Industries developments tied to the NYSE Composite highlighted pharmaceutical innovation, schizophrenia treatment progress, specialty therapies, and broader healthcare sector activity.
